(Reuters) - GSK CEO Emma Walmsley's total pay in 2023 was 12.7 million pounds ($16.05 million), a 51% increase from 2022, thanks to a big jump in performance-related pay, the British drugmaker's annual report showed on Friday.
Walmsley's total remuneration included 11.1 million pounds in performance bonuses and awards. Her total pay in 2022 was 8.4 million pounds.
Rival AstraZeneca's top boss Pascal Soriot's 2023 remuneration was higher at 16.9 million pounds.
($1 = 0.7914 pounds)
(Reporting by Anchal Rana and Prerna Bedi in Bengaluru; Editing by Shweta Agarwal)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 12,370 GBX | +0.31% | +2.66% | 240B | ||
| 1,800 GBX | +1.07% | +3.81% | 91.83B | ||
Emma N.
Walmsley is currently the Chief Executive Officer & Executive Director at GSK Plc since 2017.
She is also the Chief Executive Officer at GlaxoSmithKline Australia Pty Ltd.
Additionally, she serves as an Independent Director at Microsoft Corp.
and as a Member at Stanford Medicine.
Previously, Ms. Walmsley held the position of Chief Executive Officer at GlaxoSmithKline Consumer Healthcare Pte Ltd.
and GlaxoSmithKline Consumer Healthcare Holdings Ltd.
She was also a Non-Executive Director at Diageo Plc in 2016.
Furthermore, she worked as the General Manager-Consumer Products at L'Oreal (China) Co., Ltd.Ms. Walmsley completed her graduate degree at the University of Oxford.
| Linked companies | |
|---|---|
| GSK PLC | Chief Executive Officer |
Glaxosmithkline Australia Pty Ltd.
 Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Chief Executive Officer |
